XL-R3TA 25mg

XL-R3TA is a triple-agonist research peptide that engages GLP-1, GIP, and glucagon receptor pathways in controlled in-vitro studies.

XL-R3TA — 25 mg | Research Use Only

This listing provides a research-grade, lyophilised peptide for cell-based and biochemical model systems. Investigations focus on molecular mechanisms and assay readouts only.
For laboratory research only. Not for human use.

Key features

• Triple-agonist (GLP-1/GIP/GCGR) (GLP-3) peptide analogue for in-vitro receptor-signalling and SAR studies.
• Supplied as a lyophilised solid for straightforward handling and storage.
• Unit size: 25 mg per vial.
• Each batch released after stringent internal quality checks.

Specifications for XL-R3TA

 

• Product name: XL-R3TA
• Synonyms: XL R3TA (research code)
• Class: Peptide analogue (research use)
• Form: Lyophilised powder
• Unit size: 25 mg
• Appearance: White to off-white solid
• Note: Counter-ion/hydration state may vary. Refer to the vial label for lot-specific details.

Handling & storage of XL-R3TA

1. Storage (dry): Keep vials at 2–8 °C, protected from light and moisture.
2. Reconstitution: For step-by-step guidance, see our internal guide:
   Reconstituting & Storage.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and related mitochondrial/metabolic companions such as
MOTS-c 10 mg and
NAD+.

About XL-R3TA in research

Researchers employ XL-R3TA to examine peptide–receptor engagement across GLP-1, GIP, and glucagon pathways (GLP3), map downstream second-messenger responses, and compare potency/selectivity across assay systems—exclusively in controlled, non-clinical in-vitro environments.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.

Legal & safety

XL Peptides supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics; not for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will handle the material in line with your institution’s policies and applicable laws.

FAQs about XL-R3TA

What is XL-R3TA?
A research-grade triple-agonist peptide analogue used to study GLP-1/GIP/glucagon receptor pharmacology and second-messenger signalling in vitro.

How should I store the peptide?
Keep lyophilised vials at 2–8 °C away from light and moisture. After reconstitution, store at 2–8 °C, protect from light, and avoid repeated temperature cycling.

Where can I find reconstitution guidance?
See our step-by-step internal guide:
Reconstituting & Storage.

Is this product for human use?
No. This material is for research only and is not intended for human consumption or clinical applications.

External resources for researchers

• PubMed — GLP-1/GIP/glucagon triple-agonist (search)
• UniProt — GLP1R (human)
• UniProt — GIPR (human)
• UniProt — GCGR (human)
• KEGG — Glucagon signalling pathway

Related research products

• MOTS-c 10 mg
• NAD+
• Bacteriostatic Water 10 ml

Disclaimer

Used solely for in vitro experiments and cannot be:

– Used in clinical trials involving humans
– Administered to humans as part of an experiment or investigation
– Supplied to another party for human investigational use

 

XL-R3TA is supplied strictly for laboratory research purposes only.
This material is not intended for human or animal use, and must not be purchased, possessed, or applied for any purpose other than lawful scientific research.
By purchasing this product, you confirm that you are a qualified researcher or institution using it solely within controlled, non-clinical experimental settings in accordance with applicable laws and safety regulations.